Description | This antibody is a human neutralizing antibody clone SNV-42 recognizing the SNV Gn (Sin Nombre virus surface glycoprotein). It interferes with both receptor recognition and fusion during host-cell entry. It shows exceptionally potent neutralizing activity for SNV in vitro. This product has been tested using Enzyme-linked immunosorbent assay, Bio-layer interferometry and Neutralization assay. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Sin Nombre virus (SNV) |
Epitope | SNV-42 binds to domain B and the E3-like domain of SNV Gn. |
Neutralization Mechanism | SNV-42 disrupts recognition of sEC1-EC2 and mediates neutralizing activity after the virus particle attaches to cells. |
IC50 | 21.4 ng/mL |
Affinity | 1.0 pM |
Isotype | Human IgG |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA; BLI; Neut |
Application Notes | Bio-layer interferometry (BLI): Antibody was allowed to associate with SNV GnH for 300 s in a serial dilution scheme starting at 200 nM at a 1:2 dilution. Neutralization assay (Neut): VSV/SNV were mixed with mAb in duplicate in a volume of 100 µl using DMEM and incubated for 1 h at 37°C. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | SNV Gn |
Alternative Name | Sin Nombre virus surface glycoprotein |
Research Area | Infectious Disease |
Related Disease | Severe respiratory failure |